Li Yan, Pan Fei, Sun Gang, Wang Zi-Kai, Meng Ke, Peng Li-Hua, Lu Zhong-Sheng, Dou Yan, Yan Bin, Liu Qing-Sen
Department of Gastroenterology and Hepatology, Chinese PLA General Hospital, Beijing, People's Republic of China.
Ther Clin Risk Manag. 2021 Nov 3;17:1153-1161. doi: 10.2147/TCRM.S332838. eCollection 2021.
The present study aimed to analyze the risk factors and clinical outcomes of the incomplete endoscopic resection of rectal neuroendocrine tumors (rNETs).
This study retrospectively analyzed the cases of 428 patients with rNETs who had undergone endoscopic treatment in the Department of Gastroenterology at the PLA General Hospital, China, between January 2010 and September 2019.
Of the 428 patients with rNETs, 266 were men (62.1%) and 162 were women (37.9%). Of these, 54 had been pathologically diagnosed with positive incisal margins without lymphatic vessel invasion, and the incomplete resection (R1) rate was 12.6%. Among the R1 patients, 28 had received endoscopic submucosal dissection, 22 had received endoscopic mucosal resection, two had received snare resection, and two had undergone removal with forceps. In addition, there were 31 cases of grade G1 R1 resection (11.2%; 31/277), 13 cases of grade G2 R1 resection (23.2%; 13/56), and 10 cases whose grading was not described. The univariate analysis showed the pathological grade was statistically correlated with R1 resection (P < 0.05), and the grade G2 R1 resection rate was higher than that of grade G1. The multivariate logistic regression analysis showed that grade G2 was an independent risk factor leading to R1 resection (P = 0.02). All patients with R1 resection were followed up for 10-110 months, with an average of 38 months. No salvage treatment was performed. The endoscopic monitoring showed there were no recurrences during the follow-up period.
Endoscopic resection is a good option for rNETs, with a high complete resection rate and good prognosis, with rare recurrence even if endoscopic resection is not complete.
本研究旨在分析直肠神经内分泌肿瘤(rNETs)内镜下切除不完全的危险因素及临床结局。
本研究回顾性分析了2010年1月至2019年9月期间在中国人民解放军总医院消化内科接受内镜治疗的428例rNETs患者的病例。
428例rNETs患者中,男性266例(62.1%),女性162例(37.9%)。其中,54例经病理诊断切缘阳性但无淋巴管侵犯,不完全切除(R1)率为12.6%。在R1组患者中,28例行内镜黏膜下剥离术,22例行内镜黏膜切除术,2例行圈套切除术,2例行钳除术。此外,有31例G1级R1切除(11.2%;31/277),13例G2级R1切除(23.2%;13/56),10例未描述分级。单因素分析显示病理分级与R1切除有统计学相关性(P<0.05),G2级R1切除率高于G1级。多因素logistic回归分析显示G2级是导致R1切除的独立危险因素(P = 0.02)。所有R1切除患者均随访10 - 110个月,平均38个月。未进行挽救性治疗。内镜监测显示随访期间无复发。
内镜切除是rNETs的良好选择,完全切除率高,预后良好,即使内镜切除不完全,复发也罕见。